Thomas L. Laughlin , IV
Scott & Scott Attorneys at Law LLP
- Address of record
- The Helmsley Building, 230 Park Avenue, Ste 24th Floor, New York, NY 10169, 212-223-6444
- Phone
- (212) 223-6444
Contact details as filed with the court in the cases below.
Case history
Publicly tracked matters where this attorney is listed as counsel.
FibroGen, Inc. Securities Litigation Settlement
FibroGen and its executives allegedly misrepresented the safety profile and Phase III trial results of its anti-anemia drug Roxadustat in filings with the FDA. Investors claim the company's stock price was artificially inflated by these false statements and declined when the truth was revealed. The defendants deny all allegations of wrongdoing.
- Settlement fund
- $28.5M
- Claim deadline
- Represents
- Stefano Branca, Guiliana Mollo
Ripple Labs XRP Securities Class Action
Ripple Labs and its CEO Bradley Garlinghouse are being sued over allegations related to the sale of XRP cryptocurrency. The lawsuit alleges federal and California state securities law violations regarding how XRP was sold to purchasers in the United States.
- Claim deadline
- Represents
- Avner Greenwald
“Recovery” and “exposure” refer to total disclosed settlement funds in associated cases, not money personally won or lost by an attorney. Settlements generally resolve disputed allegations without a finding that either side won. Data comes from public court dockets and may be incomplete.